1,597 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 680 increasing their positions, 576 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% more funds holding

Funds holding: 1,5381,597 (+59)

1.05% more ownership

Funds ownership: 78.09%79.15% (+1.1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,597
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
79
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$7.72B
2 +$2.26B
3 +$592M
4
Barclays
Barclays
United Kingdom
+$248M
5
Goldman Sachs
Goldman Sachs
New York
+$164M

Top Sellers

1 -$1.36B
2 -$392M
3 -$151M
4
Primecap Management
Primecap Management
California
-$148M
5
O
OrbiMed
New York
-$148M
Name Holding Trade Value Shares
Change
Change in
Stake
1026
$937K
1027
$936K
1028
$930K
1029
$927K
1030
$926K
1031
$920K
1032
$918K
1033
$913K
1034
$908K
1035
$906K
1036
$902K
1037
$901K
1038
$899K
1039
$892K
1040
$889K
1041
$880K
1042
$875K
1043
$874K
1044
$870K
1045
$870K
1046
$868K
1047
$860K
1048
$858K
1049
$857K
1050
$851K